Bob Uger PhD

Dr. Uger is responsible for developing and implementing our scientific direction, and oversees both internal product development and external research discovery programs. He also acts as our scientific liaison with respect to global collaborations with academic and hospital research scientists. Dr. Uger was previously Vice-President, Research & Development at Trillium Therapeutics (private company). He joined Trillium from Aventis Pasteur where he was a Senior Research Scientist involved in cancer vaccine research. He received his Ph.D. in immunology from the University of Toronto